索拉非尼治疗晚期非小细胞肺癌患者不良反应观察及护理  

作　　者：吴悠[1] 来纯云[1] 

机构地区：[1]中国人民解放军总医院呼吸内科三病区,北京100853

出　　处：《现代临床护理》2011年第3期39-40,70,共3页Modern Clinical Nursing

摘　　要：目的探讨索拉非尼治疗晚期非小细胞肺癌患者不良反应的观察及护理要点。方法对3例晚期非小细胞肺癌患者给予索拉非尼治疗,观察患者不良反应发生情况,并给予对症护理。结果药物化疗期间,3例患者均出现手足综合症,高血压,消化道反应(2例出现腹泻,1例出现恶心),经对症处理后,患者均能顺利完成药物化疗。结论索拉非尼化疗期间,应密切监测患者不良反应发生情况,及时采取相应护理措施,以便提高患者治疗的耐受性、依从性,使化疗过程顺利完成。Objective To investigate the key points of nursing the adverse drug reactions caused by Sorafenib in non-small cell lung cancer.Methods Three elderly NSCLC patients were treated with administration of Sorafenib.The resulting adverse drug reactions were observed,and the corresponding nursing was provided.Results Hand-foot syndrome,hypertension and digestive tract reactions occurred in three cases,diarrhea occurred in two cases and nausea in one case.After symptomatic treatment,all patients went through chemotherapy.Conclusions Patients＇ adverse reactions need to be closely observed during administration of Sorafenib.The corresponding nursing measures help improve patients＇ tolerance and compliance and are decisive for the smooth completion of chemotherapy.

关 键 词：索拉非尼 非小细胞肺癌 不良反应 护理 

分 类 号：R734.2[医药卫生—肿瘤]